Hosted on MSN1mon
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Foods imported to the United States also must comply with the requirements. “Today’s action by FDA is long overdue, is a small step in the right direction, and hopefully signals a renewed ...
Hosted on MSN2mon
What to Know About the FDA’s New Definition of ‘Healthy’ Foods
The U.S. Food and Drug Administration (FDA ... To make spotting these new-found healthy foods easier for all, the FDA is developing a symbol that manufacturers can put on their packaging if ...
Yahoo Finance5d
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
JERSEY CITY, N.J., March 9, 2025 /PRNewswire/ -- Celltrion today announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO ® (omalizumab-igec) as the first and only biosimilar ...
The Straits Times19d
US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
WASHINGTON – The US Food and Drug Administration (FDA) is asking some of its recently fired scientists if they will come back to their jobs, including some employees reviewing tycoon Elon Musk ...
USA Today21d
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
The Alliance wrote to the FDA last year, saying more than 200,000 prescriptions for semaglutide drugs not manufactured by Novo Nordisk were being filled by U.S. patients each month, and the ...
Nasdaq1mon
U.S. FDA Approves Pfizer's ADCETRIS Combo For Relapsed Or Refractory Large B Cell Lymphoma
(RTTNews) - Pfizer Inc. (PFE) Wednesday announced the FDA approval of its supplemental ... DLBCL is its most common and aggressive form, with over 25,000 U.S. cases yearly. Up to 40% relapse ...
Yahoo Finance24d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
February 18, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions fo ...
Swedish Orphan Biovitrum AB: US FDA grants Priority Review to Sobi's supplemental Biologics Licence Application (sBLA) for Gamifant (emapalumab-lzsg)
Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) ...